The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Diffusing capacity for carbon monoxide (DLCO) change and outcome in advanced non-small cell lung cancer (aNSCLC) treated with immune checkpoint inhibitors (ICIs).
 
Angela Montes
Speakers' Bureau - Astellas Pharma; Roche
Travel, Accommodations, Expenses - Pfizer
 
Alfredo Sanchez
Honoraria - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; MSD Oncology; Novartis; Roche/Genentech; Sanofi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; Roche/Genentech; Sanofi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; MSD Oncology; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; pfizer; Roche; Sanofi
 
Maria Arnal Rondán
No Relationships to Disclose
 
Sara Cases
No Relationships to Disclose
 
Jorge Soler
No Relationships to Disclose
 
Isabel Tena
No Relationships to Disclose
 
Blanca Navarro
No Relationships to Disclose
 
Daiana Timacheva
No Relationships to Disclose
 
Manuel Modesto
No Relationships to Disclose
 
David Lorente
Consulting or Advisory Role - AstraZeneca; Bristol-Meyers; Janssen Oncology; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers; Janssen Oncology; Merck/Pfizer; Merck/Pfizer; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology